THE chief executive of listed medical technology company Medigard is in the US on a deal sealing mission for the company’s retractable syringe and blood collection device.
Peter Emery is aiming to lock down both a distributor and a manufacturer for the product.
“We’re locking the doors and putting all of our focus into securing these deals,” says Emery.
The company announced in December that it had entered a heads of agreement with a US medical device manufacturer.
“It has taken a while, but we are confident we have identified a good group of people. The timing now is critical. It is frustrating being in (the) medical devices industry, but people are very happy with our products and we continue to receive good feed back.”
Chairman Don Channer and director Peter Clark are majority shareholders of Medigard, owning 50 per cent between them.
Get our daily business news
Sign up to our free email news updates.
Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support